These findings indicate that CD83‐deficient Tregs, characterized by reduced terminal differentiation and elevated GITR expression, fail to control Th2 activity, leading to severe eosinophilia and an exacerbated disease course in allergic asthma. This evidence concerns the gene CD83 and allergic asthma.